Article info
Original Article
Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery
- Correspondence to Dr Josephine S Kim, Section of Gynecologic Oncology, University of Chicago Medicine, Chicago, IL 60637, USA; josephine.kim{at}gmail.com
Citation
Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery
Publication history
- Received February 25, 2019
- Revision received May 22, 2019
- Accepted May 24, 2019
- First published July 27, 2019.
Online issue publication
September 01, 2019
Article Versions
- Previous version (27 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.